NextCure, Inc. (NXTC) stock
NXTCNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 5/30
$6.88+0.18 (+2.76%)
Close on Nov 18, 2026Market cap $31.52MP/E –Yield 0.00%
NextCure price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
NextCure's price to sales ratio was 10.8× on Apr 30, 2021, against 140.5× a year earlier.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2021 | Apr 30, 2021 | 10.8× | −1.5 |
| 2020 | Dec 31, 2020 | 12.3× | – |
See a number that looks wrong?